Use of .alpha..sub.1 -adrenoreceptor antagonists in the preventi

Details Use of .alpha..sub.1 -adrenoreceptor antagonists in the preventi Use of .alpha..sub.1 -adrenoreceptor antagonists in the preventi

1997-03-27

1999-08-10

Goldberg, Jerome D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 3150

Patent

active

059359625

ABSTRACT:
A method for treating or preventing a cancer in a mammal which comprises administering to said mammal an amount of a drug, comprising an .alpha..sub.1 -adrenoreceptor antagonist or pharmaceutically acceptable acid addition salt thereof, effective for treating or preventing the cancer.

REFERENCES:
patent: 4188390 (1980-02-01), Campbell
patent: 4758569 (1988-07-01), Swindell
patent: 5523094 (1996-06-01), Andrieu et al.
Biochemical and Biophysical Research Communications, vol. 185, No. 1, 1992, pp. 176-184.
Carcinogenesis, vol. 10, No. 1, 1989, pp. 73-78.
BR. J. Cancer, vol. 64, 1991, pp. 683-688.
Berkow et al. "The Merck Manual", 1992, pp. 1736-1737.

Affiliated with

Also associated with

Rating

Use of .alpha..sub.1 -adrenoreceptor antagonists in the preventi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of .alpha..sub.1 -adrenoreceptor antagonists in the preventi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of .alpha..sub.1 -adrenoreceptor antagonists in the preventi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1120438